Your cart is currently empty!
Tag: EU HTA regulation
Drug Value with RWE and Role of AI in EU’s JCA
Drug Value with Real-World Evidence (RWE): Opportunities, Challenges, and the Role of AI in EU’s Joint Clinical Assessment (JCA) What is Real-World Evidence and Why It Matters in the EU […]
Pharma Market Access 2025: HTA, U.S. Drug Pricing, and Tariffs
Global Pharma Market Access Under Pressure Pharma market access is no longer just a regulatory hurdle, it’s a geopolitical challenge. With the EU’s new HTA regulation, U.S. pricing reforms, potential […]
